The global blood coagulation testing market share is projected to reach USD ~7.5 billion by 2027 at a CAGR of 6.5%.
Blood Coagulation/ Clotting prevents excessive bleeding during an injury or surgery. Coagulation tests measure blood’s ability and the duration it takes to clot. These tests help clinicians to assess the risk of excessive bleeding or developing clots (thrombosis) in the blood vessels. Clinicians frequently order coagulation tests to assess blood clotting function in patients before performing surgeries or in treatments of disorders related to arteries.
Coagulation tests help in determining the probable bleeding rate in the perioperative or postoperative period. These laboratory tests are also helpful in elucidating the cause of unexplained bleeding and predicting blood clotting or thrombosis in the absence of vessel injury. The global blood coagulation testing market appears to be well-established with the availability of many well-described assays. The market is growing pervasively over the past few years
North America is forecasted to retain its leading position in the global blood testing market throughout the review period. The presence of prominent market players and well-developed healthcare sectors in the region influence the market growth, significantly.
Besides, rising prevalence of the liver disease, von Willebrand disease (vWF), and hemophilia alongside, the high healthcare expenditures, especially in the US & Canada, drive the market growth. Simultaneously, huge technological advances and increasing government support for research & development are impacting the growth of the regional market, positively.
Europe takes the second-leading position in the global blood coagulation testing market. Factors such as the presence of a large number of well-established players and their investments in R&D activities foster the growth of the regional market. Well-spread awareness driven by private and public organizations about various diseases and disorders related to liver, hemophilia, and vWF acts as a major tailwind for the European blood coagulation testing market.
The Asia Pacific blood coagulation testing market is rapidly emerging as a lucrative market globally. Factors substantiating the growth market include increasing healthcare expenditures and favorable government policies in the region. Substantial investment transpired into R&D activities, rapidly developing healthcare infrastructure and government support boost the growth of the APAC blood coagulation testing market. Furthermore, huge patient population alongside the augmenting demand for quality medical would increase the growth of the regional market.
The global blood coagulation market is segmented on the basis of product, application, test type, and end user. On the basis of the product, the market is segmented into clinical laboratory, automated testing, and semi-automated testing. On the basis of the application, the market is segmented into congenital bleeding disorders, acquired bleeding disorders, Von Willebrand disease, and hemophilia. On the basis of the test type, the market is segmented into various testing kits and others. Furthermore, the testing kits are segmented into prothrombin time (PT), activated clotting time, D dimer, and fibrinogen (FIB). On the basis of the end user, the market is segmented into academic institutions, hospitals, and diagnostic laboratories.
Some of the major players in the global blood coagulation market are F. Hoffmann-La Roche Ltd. (Europe), Alere Inc. (U.S.), Siemens Healthcare Private Limited (Europe), Accriva Diagnostics (U.S.A.), CoaguSense, Inc. (U.S.), HomoSonics LLC. (U.S.), iLine Microsystems. (Europe), Instrumentation Laboratory (U.S.), Sienco, Inc. (U.S.), SenGenix Inc. (U.S.), and Bio/Data Corporation (U.S.)
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071